title: Etiologic and immunologic characteristics of thoroughbred horses with bacterial infectious upper respiratory disease at the Seoul Race Park.
abstract: Equine respiratory disease is a common cause of poor performance and training interruptions. The higher incidence rate of infectious upper respiratory disease (IURD) in thoroughbred racehorses at the Seoul Race Park coincided with the frequent stabling season, shorter stabling periods, and younger ages in this study. Incidence rates were also correlated with significantly lower proportions of cells expressing MHC class II-, CD2 antigen-, CD4+- or CD8+-T lymphocyte-, and B lymphocyte in IURD patients compared with healthy control groups in the summer and fall and in 2-and-3-year-old groups. The data suggested that movement and new environments may have resulted in immunosuppression and inappropriate responses to respiratory pathogens in IURD patients. The IURD incidence decreased with age, perhaps by the acquisition of immunity, and study results suggested that immunologic protection was associated with IURD, particularly in young thoroughbred racehorses. Streptococci isolates were identified in 11 of 72 IURD horses, and 3 of these isolates were identified as Streptococcus. equi subsp. equi. S. equi subsp. zooepidemicus was isolated from 2 of 23 IURD horses in the spring (8.7%), 5 of 23 in the summer (21.7%), and 1 of 6 in winter (16.7%). S. equi subsp. zooepidemicus (5%) was also identified in 3 of 61 isolates from clinically normal horses. Racetracks should implement anti-IURD protective measures by assessing the capacity of equine immunologic protection at the Park and by limiting the introduction of specific respiratory pathogens (such as S. equi subsp. equi) by preventing the access of infected horses with a respiratory pathogen-free certification system prior to Park entry.
authors.affiliation: Korea Racing Authority, Gwacheon, Gyeonggi 427-711, Korea.
authors.forename: Seung-Ho
authors.initials: SH
authors.lastname: Ryu
authors.forename: Hye Cheong
authors.initials: HC
authors.lastname: Koo
authors.forename: Young Kyung
authors.initials: YK
authors.lastname: Park
authors.forename: Jun Man
authors.initials: JM
authors.lastname: Kim
authors.forename: Woo Kyung
authors.initials: WK
authors.lastname: Jung
authors.forename: William C
authors.initials: WC
authors.lastname: Davis
authors.forename: Yong Ho
authors.initials: YH
authors.lastname: Park
authors.forename: Chang-Woo
authors.initials: CW
authors.lastname: Lee
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D017931:DNA Primers; D004777:Environment; D020022:Genetic Predisposition to Disease; D006734:Horse Diseases / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology / Q000382:microbiology*; D006736:Horses; D007723:Korea; D008826:Microbial Sensitivity Tests; D016133:Polymerase Chain Reaction / Q000379:methods; D012016:Reference Values; D012141:Respiratory Tract Infections / Q000188:drug therapy / Q000209:etiology / Q000276:immunology / Q000662:veterinary*; D013290:Streptococcal Infections / Q000188:drug therapy / Q000209:etiology / Q000276:immunology / Q000662:veterinary*; D018502:Streptococcus equi / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification*
chemical_list: D000900:Anti-Bacterial Agents; D017931:DNA Primers